Operation Warp Speed's Dose Target
CNBC's segment records Moncef Slaoui setting a concrete production marker: enough doses to vaccinate 20 to 25 million Americans by early September 2020. That claim belongs to Operation Warp Speed's first phase, when mRNA was presented as a scalable response tool. The later funding and review fights do not erase the production target, but they show how quickly a platform's public story can move from dose counts to institutional resistance.






